Abstract
The predictive utility of polygenic scores is increasing, and many polygenic scoring methods are available, but it is unclear which method performs best. This study evaluates the predictive utility of polygenic scoring methods within a reference-standardized framework, which uses a common set of variants and reference-based estimates of linkage disequilibrium and allele frequencies to construct scores. Eight polygenic score methods were tested: p-value thresholding and clumping (pT+clump), SBLUP, lassosum, LDpred1, LDpred2, PRScs, DBSLMM and SBayesR, evaluating their performance to predict outcomes in UK Biobank and the Twins Early Development Study (TEDS). Strategies to identify optimal p-value thresholds and shrinkage parameters were compared, including 10-fold cross validation, pseudovalidation and infinitesimal models (with no validation sample), and multi-polygenic score elastic net models. LDpred2, lassosum and PRScs performed strongly using 10-fold cross-validation to identify the most predictive p-value threshold or shrinkage parameter, giving a relative improvement of 16-18% over pT+clump in the correlation between observed and predicted outcome values. Using pseudovalidation, the best methods were PRScs, DBSLMM and SBayesR. PRScs pseudovalidation was only 3% worse than the best polygenic score identified by 10-fold cross validation. Elastic net models containing polygenic scores based on a range of parameters consistently improved prediction over any single polygenic score. Within a reference-standardized framework, the best polygenic prediction was achieved using LDpred2, lassosum and PRScs, modeling multiple polygenic scores derived using multiple parameters. This study will help researchers performing polygenic score studies to select the most powerful and predictive analysis methods.
Highlights
IntroductionMedical care is tailored for the individual to provide improved disease prevention, prognosis, and treatment
In personalized medicine, medical care is tailored for the individual to provide improved disease prevention, prognosis, and treatment
Polygenic scores are widely used in research and could be used in a clinical setting to enhance personalized medicine
Summary
Medical care is tailored for the individual to provide improved disease prevention, prognosis, and treatment. Genetic information is used to predict rare Mendelian genetic disorders, such as breast cancer based on BRCA1/2 variants, our ability to predict common disorders using genetic information is currently insufficient for clinical implementation. Genome-wide association studies (GWAS), used to detect common genetic associations, are rapidly increasing in sample size, and are identifying large numbers of novel and robust genetic associations for health-related outcomes [3]. This growing source of information is improving our ability to predict an individual’s disease risk or measured trait based on their genetic variation [4,5]
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have